Abstract
Background Up to 80% of psychosis patients experience cognitive impairment. High heritability of both psychosis and cognition means cognitive performance could be an endophenotype for psychosis.
Methods Using samples of adults (N=4,506) and children (N=10,981), we investigated the effect of polygenic scores (PGSs) for schizophrenia and bipolar disorder on cognitive performance, and PGSs for intelligence and educational attainment on psychosis symptoms.
Results Schizophrenia PGS was negatively associated with visuospatial processing/problem-solving in the adult sample (beta: −0.0569; 95% confidence interval [CI]: −0.0926, −0.0212) and working memory (beta: −0.0432; 95% CI: −0.0697, −0.0168), processing speed (b: −0.0491; 95% CI: −0.0760, −0.0223), episodic memory (betas: −0.0581 to −0.0430; 95% CIs: −0.0847 to −0.0162), executive functioning (beta: −0.0423; 95% CI: −0.0692, −0.0155), fluid intelligence (beta: −0.0583; 95% CI: −0.0847, −0.0320), and total intelligence (beta: −0.0458; 95% CI: −0.0709, −0.0206) in the child sample. Bipolar disorder PGS was not associated with any cognitive endophenotypes studied. Lower values on the PGS for intelligence were associated with higher odds of psychosis in adults (odds ratio [OR]: 0.886; 95% CI: 0.811– 0.968) and psychotic-like experiences in children (OR: 0.829; 95% CI: 0.777–0.884). In children, a lower polygenic score for educational attainment was associated with greater odds of psychotic-like experiences (OR: 0.771; 95% CI: 0.724–0.821).
Conclusions The relationship between psychosis and cognitive impairment can be demonstrated bidirectionally at the neurobiological level. The effect of schizophrenia PGS on cognitive performance differs across the lifespan and cognitive domains. Specific cognitive domains may therefore be better endophenotypes than overall cognition.
Competing Interest Statement
S.B. has received financial support for symposia from Medice, Takeda and is on the advisory board for AGB-Pharma. All other authors report no disclosures.
Funding Statement
L.V. is supported by Medical Research Council (MR/W020238/1). E.B. is supported by Medical Research Council (G1100583, MR/W020238/1); National Institute of Health Research (NIHR200756); Mental Health Research UK - John Grace QC Scholarship 2018; Economic Social Research Council's Co-funded doctoral award; The British Medical Association's Margaret Temple Fellowship; Medical Research Council New Investigator and Centenary Awards (G0901310, G1100583); NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust and University College London (NIHR BRC UCL). K.J.'s work was undertaken as part of the UCL-Birkbeck MRC-DTP PhD program, generously funded by the Medical Research Council (MR/W006774/1). A.R.B. is funded by the Wellcome Trust through a PhD Fellowship in Mental Health Science (218497/Z/19/Z). This research was funded in whole or in part by the Wellcome Trust. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript (AAM) version arising from this submission. N.S.K. is supported by a studentship co-funded by the Economic and Social Research Council (ESRC) and Mental Health Research UK (ES/P000592/1). D.P. received the FCT 2022.00586.CEECIND fellowship (DOI: 10.54499/2022.00586.CEECIND/CP1722/CT0011). All other authors report no biomedical financial interests or potential conflicts of interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval granted by the National Health Service Multicentre Research Ethics Committee (references 03/11/090 and 19/LO/1403). Identifiable data are stored in a secure system at University College London that meets the requirements of NHS Information Governance Toolkit, ISO 27001, and all national policies.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
